Core Stabilization Exercises in Stroke (NCT05549518) | Clinical Trial Compass
CompletedNot Applicable
Core Stabilization Exercises in Stroke
Turkey (Türkiye)24 participantsStarted 2022-11-15
Plain-language summary
A stroke due to a cerebrovascular accident (CVA) is a neurological deficit characterized by the rapid settlement of signs and symptoms due to focal or global loss of cerebral function, without any apparent cause other than vascular causes. Stroke is one of the most common cardiovascular events in the world. In addition to complications such as spasticity, loss of strength, balance problems, speech and swallowing problems, pulmonary complications are also common in stroke. When the literature is examined, there are a limited number of studies evaluating respiratory functions and functional capacity as a result of core stabilization exercises applied to stroke patients. There is no study in the literature examining the results of core stabilization exercises on respiratory functions, functional capacity, trunk control, and balance in stroke patients. The aim of this study; to investigate the effects of core stabilization training applied in addition to traditional physical therapy on respiratory functions, functional capacity, trunk control, and balance in stroke individuals after cerebrovascular accidents.
Who can participate
Age range
18 Years – 65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Cerebrovascular attack due to ischemia or hemorrhage
* Over 18 years old and under 65 years old
* Diagnosed with a cerebrovascular attack at least 3 months ago
* A Mini-Mental State Test score of 24 or higher
* Brunnstrom stage 3 or higher in the upper and lower extremities
* 2 or less spasticity according to the Modified Ashworth Scale
* Stage 2 or higher according to the Functional Ambulation Classification
Exclusion Criteria:
* Having a history of additional neurological diseases or disorders other than cerebrovascular attack
* Cerebrovascular attack history more than once
* Having musculoskeletal disorders
* There are other treatments that may alter the effects of the interventions to be applied.
* Having severe aphasia, amnesia, and agnosia
* Having hearing or visual impairment
* Failure to complete the 2 Minute Walking Test
* Having a permanent pacemaker installed
* Having a history of active malignancy
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Tiffeneau ratio
Timeframe: Change from Baseline Tiffeneau ratio at 6 weeks
2
2 Minutes Walking Test
Timeframe: Change from Baseline 2 Minutes Walking Test at 6 weeks